Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics | British Journal of Cancer
De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995 - eClinicalMedicine
Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis | Scientific Reports
Breast Cancer Statistics | Susan G. Komen®
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text
De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis
Identifying the potential long-term survivors among breast cancer patients with distant metastasis - Annals of Oncology
Breast cancer survival statistics | Cancer Research UK
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Breast Cancer Survival by stage at Diagnosis - Moose and Doc
Mixed Results With Resection of Primary Tumor in Stage IV Breast Cancer - The ASCO Post
Breast cancer life expectancy | LBBC
Breast Cancer Recurrence | Breast Cancer Surgery Melbourne, VIC
Breast Cancer Survival by stage at Diagnosis - Moose and Doc
Breast Cancer Survival by stage at Diagnosis - Moose and Doc
Breast Cancer Survival Rates: Prognosis by Age, Race & More
The curability of breast cancer: present and future - ScienceDirect
De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis
Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study - Maaren - 2019 - International Journal of Cancer - Wiley Online Library
A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns | SpringerLink
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - The Lancet Oncology
Kaplan-Meier estimates of breast cancer-specific survival in the... | Download Scientific Diagram
A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns | SpringerLink
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years | NEJM
Study estimates number of U.S. women living with metastatic breast cancer - NCI
Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study - Maaren - 2019 - International Journal of Cancer - Wiley Online Library
